GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Kraig Biocraft Laboratories Inc (OTCPK:KBLB) » Definitions » Interest Expense

KBLB (Kraig Biocraft Laboratories) Interest Expense : $-0.53 Mil (TTM As of Dec. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Kraig Biocraft Laboratories Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Kraig Biocraft Laboratories's interest expense for the three months ended in Dec. 2024 was $ -0.14 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.53 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Kraig Biocraft Laboratories's Operating Income for the three months ended in Dec. 2024 was $ -0.72 Mil. Kraig Biocraft Laboratories's Interest Expense for the three months ended in Dec. 2024 was $ -0.14 Mil. Kraig Biocraft Laboratories did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Kraig Biocraft Laboratories Interest Expense Historical Data

The historical data trend for Kraig Biocraft Laboratories's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kraig Biocraft Laboratories Interest Expense Chart

Kraig Biocraft Laboratories Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.39 -0.66 -0.61 -0.49 -0.53

Kraig Biocraft Laboratories Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.13 -0.13 -0.13 -0.13 -0.14

Kraig Biocraft Laboratories Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kraig Biocraft Laboratories  (OTCPK:KBLB) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Kraig Biocraft Laboratories's Interest Expense for the three months ended in Dec. 2024 was $-0.14 Mil. Its Operating Income for the three months ended in Dec. 2024 was $-0.72 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was $0.04 Mil.

Kraig Biocraft Laboratories's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Kraig Biocraft Laboratories did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


Kraig Biocraft Laboratories Business Description

Traded in Other Exchanges
N/A
Address
2723 South State Street, Suite 150, Ann Arbor, MI, USA, 48104
Kraig Biocraft Laboratories Inc is engaged in the development of high-strength fibers using recombinant DNA technology mainly for commercial applications. It uses genetic engineering technologies to develop fibers with greater strength, resiliency, and flexibility for use in its target markets, namely the textile, specialty fiber, and technical textile industries. Its products include Monster Silk, which incorporates the natural elasticity of spider silk to make a silk fiber that is more flexible than conventional silk fibers and textiles; and Dragon Silk, which combines the elasticity of Monster Silk with additional high strength elements of native spider silk; Spydasilk; and Spydra.
Executives
Jonathan Richard Rice officer: COO 2723 S STATE STREET, SUITE 150, ANN ARBOR MI 48104
Kimberly Kraig Thompson director, 10 percent owner, officer: CEO, CFO 2723 S STATE STREET, SUITE 150, ANN ARBOR MI 48401